Calumet (NASDAQ:CLMT) Given New $37.00 Price Target at TD Cowen

Calumet (NASDAQ:CLMT – Get Free Report) had its price objective decreased by TD Cowen from $40.00 to $37.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the oil and gas company’s stock. TD Cowen‘s target price suggests a potential upside of 23.32% from the stock’s previous close.

A number of other analysts have also recently issued reports on CLMT. UBS Group lifted their target price on shares of Calumet from $26.00 to $47.00 and gave the company a “neutral” rating in a research note on Tuesday, August 25th. HC Wainwright lifted their price objective on shares of Calumet from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Wall Street Zen upgraded shares of Calumet from a “hold” rating to a “buy” rating in a report on Saturday. The Goldman Sachs Group restated a “neutral” rating and issued a $57.00 price objective on shares of Calumet in a report on Wednesday, October 21st. Finally, Citigroup reaffirmed a “buy” rating on shares of Calumet in a research report on Monday, August 10th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Calumet currently has a consensus rating of “Hold” and an average price target of $54.00.

Get Our Latest Stock Report on Calumet

Calumet Stock Performance

NASDAQ CLMT traded down $1.82 during trading hours on Wednesday, hitting $30.00. 86,349 shares of the company’s stock were exchanged, compared to its average volume of 1,292,541. The firm has a market capitalization of $2.64 billion, a P/E ratio of -13.40, a price-to-earnings-growth ratio of 0.21 and a beta of 0.65. The business’s 50 day moving average is $50.99 and its 200-day moving average is $39.44. Calumet has a 12-month low of $17.85 and a 12-month high of $59.87.

Calumet (NASDAQ:CLMT – Get Free Report) last released its quarterly earnings results on Friday, November 6th. The oil and gas company reported $2.91 EPS for the quarter, topping the consensus estimate of $1.63 by $1.28. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.34 billion. Calumet had a negative return on equity of 32.93% and a negative net margin of 3.73%. The company’s revenue was up 56.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.61 earnings per share. As a group, equities research analysts anticipate that Calumet will post 3.09 EPS for the current fiscal year.

Hedge Funds Weigh In On Calumet

Institutional investors and hedge funds have recently modified their holdings of the company. Fifth Third Bancorp increased its stake in shares of Calumet by 11.3% during the 2nd quarter. Fifth Third Bancorp now owns 3,407 shares of the oil and gas company’s stock valued at $123,000 after acquiring an additional 346 shares during the last quarter. Global Retirement Partners LLC grew its position in shares of Calumet by 20.8% during the third quarter. Global Retirement Partners LLC now owns 2,055 shares of the oil and gas company’s stock worth $108,000 after buying an additional 354 shares in the last quarter. GAMMA Investing LLC lifted its stake in Calumet by 63.3% during the third quarter. GAMMA Investing LLC now owns 926 shares of the oil and gas company’s stock worth $49,000 after purchasing an additional 359 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in Calumet by 1.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,852 shares of the oil and gas company’s stock valued at $1,075,000 after purchasing an additional 468 shares during the period. Finally, Caldwell Sutter Capital Inc. grew its position in Calumet by 2.7% in the 2nd quarter. Caldwell Sutter Capital Inc. now owns 20,000 shares of the oil and gas company’s stock worth $720,000 after purchasing an additional 517 shares during the last quarter. 34.41% of the stock is currently owned by hedge funds and other institutional investors.

Calumet Company Profile

(Get Free Report)

Calumet, Inc. is a U.S.-based producer of specialty hydrocarbon products, renewable fuels and conventional fuels. Its products serve customers in industries such as manufacturing, transportation, energy and consumer goods. The company’s specialty products include lubricating oils, solvents, waxes, petrolatums and asphalt. It also produces gasoline, diesel and other fuels, and through its Montana Renewables business makes lower-carbon fuels, including sustainable aviation fuel and renewable diesel.

Recommended Stories

Analyst Recommendations for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.